Cimzia reg; Is The First Anti-TNF Shown To Inhibit Progression Of Joint Damage As Early As 16 Weeks In Rheumatoid Arthritis
Added: 18 июня 2008
Last relative articles:
- Patients Taking Cymbalta reg; Reported Reduced Pain Severity Of Osteoarthritis Of The Knee In New Study
- Actemra Is First Biologic Agent To Show Better Efficacy Than Methotrexate In RA
- Joint Damage Is Inhibited With Enbrel reg; Etanercept Plus Methotrexate In Patients With Early Active Rheumatoid Arthritis
- Novel DNA Microarray Chip Predicts Functional Impairment And Remission In Rheumatoid Arthritis
- Oily Fish Can Protect Against RA, But Smoking And Psychosocial Stress Increase Its Risk
- Specific Mutations In The IL2RA Gene Associated With Juvenile Idiopathic Arthritis
- Rheumatoid Arthritis Is A Risk Factor For Cardiovascular Disease
- In Risk Of Severe Cardiovascular Events, Rheumatoid Arthritis Factors Equal To Cardiovascular Factors
- Recommendations For Rheumatoid Arthritis Therapy Presented By American College Of Rheumatology
- Increased Incidence Of Melanoma Found In Rheumatoid Arthritis Patients Treated With Methotrexate
Comments: [0] / Post comment:
06 Jan 2009 23:58:53
UCB Receives Complete Response Letter From US FDA for Use of ... - MSNBC
UCB Receives Complete Response Letter From US FDA for Use of ... MSNBC - As a prerequisite for approval of Cimzia , the FDA has requested a new safety update with all clinical data including new data generated since the filing of ... UCB's Cimzia receives complete response letter for rheumatoid ... UCB stock down as FDA asks for more Cimzia data STOCKS NEWS EUROPE-UCB shares fall on US drug delay
06 Jan 2009 09:06:19
European Factors -- Shares set for higher opening - Reuters
European Factors -- Shares set for higher opening Reuters - ... Research) The Belgian pharmaceutical group says the US Food and Drug Administration (FDA) had requested a new safety update on its Cimzia drug in ...
06 Jan 2009 08:41:25
French and Benelux stocks - Factors to watch on Jan 6 - Forbes
French and Benelux stocks - Factors to watch on Jan 6 Forbes, NY - The Belgian pharmaceutical group says the US Food and Drug Administration (FDA) had requested a new safety update on its Cimzia drug in rheumatoid arthritis ...
06 Jan 2009 08:11:54
Think Twice Before You Pop That Pill - theTrumpet.com
Think Twice Before You Pop That Pill theTrumpet.com, OK - In addition, the entire class of arthritic medications such as Remicade, Enbrel, Humira and Cimzia were linked to the development of lymphoma and other ...
Source: http://thetrumpet.com/index.php
05 Jan 2009 22:19:50
Thriving in 2008: Approvals, Deals and Other Silver Linings - TMCnet
Thriving in 2008: Approvals, Deals and Other Silver Linings TMCnet - 27), UCB SA's Cimzia (certolizumab pegol, April 22) and Amgen Inc.'s Nplate (romiplostim, Aug. 22). The FDA's Center for Biologics Evaluation and Research ...
05 Jan 2009 19:42:12
BRIEF-UCB says FDA wants new safety update on Cimzia in rheumatoid ... - Interactive Investor
BRIEF-UCB says FDA wants new safety update on Cimzia in rheumatoid ... Interactive Investor, UK - Interactive Investor Trading Limited, trading as "Interactive Investor", is authorised and regulated by the Financial Services Authority. ...
Source: http://iii.co.uk/news/
05 Jan 2009 16:06:21
XOMA Appoints Fred Kurland as Chief Financial Officer - Reuters
XOMA Appoints Fred Kurland as Chief Financial Officer Reuters - ... plaque psoriasis, LUCENTIS(r) (ranibizumab injection) for wet age-related macular degeneration and CIMZIA (r) (certolizumab pegol) for Crohn's disease. ...
01 Jan 2009 15:09:42
2008 was a year for dangerous Drugs - Examiner.com
Examiner.com 2008 was a year for dangerous Drugs Examiner.com - In addition the entire class of arthritic medications such as Remicade, Enbrel, Humira, and Cimzia were linked to the development of lymphoma and other ...
24 Dec 2008 19:16:51
FDA Warning Over Humira Ad - Newsinferno.com
FDA Warning Over Humira Ad Newsinferno.com, NY - In September, we reported that Federal regulators ordered the makers of Humira, Cimzia , Enbrel, and Remicade to strengthen the existing warnings about ...
16 Dec 2008 15:30:30
High Growth Forecasted for the World Monoclonal Antibody Based ... - MarketWatch
High Growth Forecasted for the World Monoclonal Antibody Based ... MarketWatch - ... and Developments II-47 Amgen Introduces Vectibix II-47 Trevigen Introduces Mouse Monoclonal Antibody II-47 UCB Receives FDA Approval for Cimzia (R) II-47 ...